Nama's AI scorecard currently rates CVS Health Hold (5.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CVS's P/E ratio?

CVS Health trades at a trailing price-to-earnings ratio of 10.1.

When does CVS report earnings?

CVS Health's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $1.24.

What is the CVS price target?

The median analyst price target from 25 analysts is $113.00, with a range of $103.00 – $146.00.

Is CVS Shariah compliant?

Nama's AAOIFI-style screen reads CVS Health as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does CVS pay a dividend?

Yes — CVS Health's dividend yield is 3.2%.

Nama Insights

CVS Health (CVS)

Healthcare · Healthcare Plans · NYSE

S&P 500

CVS Health (CVS) is a Healthcare company in the Healthcare Plans industry. It has a market capitalization of $107.28B, a trailing price-to-earnings ratio of 10.1 and a free-cash-flow yield of 7.3%. Over the most recent reported fiscal year, revenue grew 7.8% and free cash flow per share grew 22.5%. Nama's AI scorecard rates it Hold, 5.3 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Hold · 5.3/10

The sections balance. As of Nov 7, 2026.

Momentum

Middle · +11.8% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-24.6%

How far the last close sits under the highest price of the past five years.

Market cap	$107.28B
Trailing P/E	10.1
Price / book	1.3
Price / sales	0.3
FCF yield	7.3%
Dividend yield	3.2%
Gross margin	14.2%
Operating margin	3.4%
Net margin	1.2%
Revenue growth (YoY)	+7.8%
Revenue growth (3-yr annual)	+7.6%
EPS growth (YoY)	+24.5%
FCF/share growth (YoY)	+22.5%
Beta	0.6
Exchange	NYSE
Sector	Healthcare
Industry	Healthcare Plans

CVS earnings

Next report: Feb 9, 2027 (Q4 2026, EPS estimate $1.24). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 4, 2026	$2.09	$1.65	+26.7%	$108.40B
Q2 2026	Aug 5, 2026	$2.58	$1.85	+39.5%	$106.10B
Q1 2026	May 6, 2026	$2.57	$2.21	+16.3%	$100.43B
Q4 2025	Feb 10, 2026	$1.09	$1.00	+9.0%	$105.69B

CVS analyst price target

Median target $113.00 from 25 analysts, ranging $103.00 – $146.00.

Healthcare Plans peers

Ticker	Company	Market cap	P/E
UNH	UnitedHealth Group	$353.17B	19.3
ELV	Elevance Health	$91.96B	14.0
CI	Cigna Group	$77.58B	9.3
HUM	Humana	$52.08B	32.7
CNC	Centene	$34.53B	13.2
MOH	Molina Healthcare	$10.87B	104.5
OSCR	Oscar Health	$9.46B	12.7
PGNY	Progyny	$2.58B	17.0

Explore live CVS data on Nama Insights →

Recent Congressional trades

CVS Health trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Dwight Evans	House	Sell	$1,001 - $15,000	May 15, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Valerie Hoyle	House	Sell	$1,001 - $15,000	Oct 10, 2025
Valerie Hoyle	House	Buy	$1,001 - $15,000	Sep 12, 2025
Adam Smith	House	Sell	$1,001 - $15,000	Aug 8, 2025
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	May 31, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	May 14, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	Mar 27, 2025

CVS FAQ

Is CVS a buy?: Nama's AI scorecard currently rates CVS Health Hold (5.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CVS's P/E ratio?: CVS Health trades at a trailing price-to-earnings ratio of 10.1.
When does CVS report earnings?: CVS Health's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $1.24.
What is the CVS price target?: The median analyst price target from 25 analysts is $113.00, with a range of $103.00 – $146.00.
Is CVS Shariah compliant?: Nama's AAOIFI-style screen reads CVS Health as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does CVS pay a dividend?: Yes — CVS Health's dividend yield is 3.2%.